Mount Sinai Health System in New York has selected Toronto-based Signal 1's AI management platform to oversee and manage its broad deployment of artificial intelligence tools, aiming to ensure safety and efficiency at scale.
- Mount Sinai integrates Signal 1’s platform to govern AI across its network.
- Signal 1 pivoted from AI applications to AI oversight infrastructure in 2025.
- Goal is to balance innovation with safety and impact monitoring at scale.
What happened
Mount Sinai Health System, a leading academic medical network in the US encompassing seven hospitals and three schools, has announced it will adopt Signal 1’s AI management platform. Signal 1, a Toronto-based startup, provides software designed to track, evaluate, and optimize the deployment of AI tools in healthcare environments. This partnership follows similar moves by other US health systems focused on AI governance.
Signal 1’s founders, who transitioned from prominent roles in banking and academia in 2022, initially developed various AI applications for healthcare before pivoting their focus to building an AI oversight platform. The company commercialized this governance infrastructure in 2025 to meet increasing demand from hospitals in managing AI solutions effectively.
Why it matters
As healthcare systems adopt more AI technologies, questions have shifted from whether to use AI to how to manage it safely and effectively. Improperly governed AI could threaten patient safety and privacy, making robust oversight essential. Mount Sinai’s move signals a growing recognition among top-tier health providers that AI must be monitored continuously to mitigate risks without compromising innovation.
The adoption of Signal 1’s platform highlights the emerging market for AI governance solutions in healthcare. Mount Sinai’s chief digital transformation officer emphasized the need to monitor AI performance, safety, and impact at scale, showing that leading institutions value infrastructure that supports responsible AI usage alongside rapid technological progress.
What to watch next
Observing how Mount Sinai implements Signal 1’s platform will provide insights into the practical challenges and benefits of AI governance in complex medical environments. Success here could encourage other healthcare systems, particularly in North America, to adopt similar oversight technologies.
Additionally, tracking Signal 1’s growth and partnership expansion may reveal broader industry trends around AI risk management in healthcare. The balance between leveraging advanced AI tools and ensuring patient privacy and safety will remain a critical area of focus as digital transformation accelerates.